iSpecimen, Inc. (ISPC)
0.6587
-0.04
(-5.43%)
USD |
NASDAQ |
Nov 13, 16:00
0.6517
-0.01
(-1.06%)
After-Hours: 19:59
iSpecimen Enterprise Value : -3.171M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | -3.171M |
| November 12, 2026 | -3.113M |
| November 11, 2026 | -3.094M |
| November 10, 2026 | -3.051M |
| November 09, 2026 | -2.971M |
| November 06, 2026 | -2.934M |
| November 05, 2026 | -2.944M |
| November 04, 2026 | -2.890M |
| November 03, 2026 | -2.971M |
| November 02, 2026 | -2.906M |
| October 30, 2026 | -2.917M |
| October 29, 2026 | -2.967M |
| October 28, 2026 | -2.843M |
| October 27, 2026 | -2.846M |
| October 26, 2026 | -2.895M |
| October 23, 2026 | -2.930M |
| October 22, 2026 | -2.906M |
| October 21, 2026 | -2.815M |
| October 20, 2026 | -2.712M |
| October 19, 2026 | -2.788M |
| October 16, 2026 | -2.778M |
| October 15, 2026 | -2.605M |
| October 14, 2026 | -2.621M |
| October 13, 2026 | -2.529M |
| October 12, 2026 | -2.529M |
| Date | Value |
|---|---|
| October 09, 2026 | -2.453M |
| October 08, 2026 | -2.514M |
| October 07, 2026 | -2.499M |
| October 06, 2026 | -2.544M |
| October 05, 2026 | -2.575M |
| October 02, 2026 | -2.529M |
| October 01, 2026 | -2.438M |
| September 30, 2026 | -2.377M |
| September 29, 2026 | -2.301M |
| September 28, 2026 | -2.331M |
| September 25, 2026 | -2.255M |
| September 24, 2026 | -2.270M |
| September 23, 2026 | -2.331M |
| September 22, 2026 | -2.270M |
| September 21, 2026 | -2.164M |
| September 18, 2026 | -2.149M |
| September 17, 2026 | -2.118M |
| September 16, 2026 | -2.088M |
| September 15, 2026 | -2.149M |
| September 14, 2026 | -1.936M |
| September 11, 2026 | -1.936M |
| September 10, 2026 | -1.890M |
| September 09, 2026 | -1.814M |
| September 08, 2026 | -1.753M |
| September 04, 2026 | -1.829M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 7.107M |
| SCWorx Corp. | -1.154M |
| Health Catalyst, Inc. | 51.76M |
| GoodRx Holdings, Inc. | 1.454B |
| Claritev Corp. | 5.171B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.363M |
| Revenue (Quarterly) | 0.1519M |
| Total Expenses (Quarterly) | 1.515M |
| EPS Diluted (Quarterly) | -0.9773 |
| Gross Profit Margin (Quarterly) | -87.43% |
| Profit Margin (Quarterly) | -897.2% |
| Earnings Yield | -7.63K% |
| Normalized Earnings Yield | -7633.78 |